Shuzhong Cui

4.8k citations
91 papers · 2.9k indexed · 2 hit papers · h-index 25
Topics
Intraperitoneal and Appendiceal Malignancies (17 papers)MicroRNA in disease regulation (13 papers)Cancer-related molecular mechanisms research (11 papers)

In The Last Decade

Shuzhong Cui

87 papers receiving 2.9k citations

Hit Papers

A Multifunctional Cascade Bioreactor Based on Hollow‐Stru...201920262021202320192020100200300400

Peers

Shuzhong Cui
Comparison fields: 5 of 116
  • Molecular Biology 1.4k
  • Cancer Research 884
  • Biomedical Engineering 699
  • Oncology 668
  • Immunology 455
Replace Shuo Wang with:
Shuo Wang China
Chun‐Wei Peng China
Ciprian Tomuleasa Romania
Mohammad Hojjat‐Farsangi Sweden
Minjie Wei China
Wanhai Xu China
Weiping Qian China
Chong-xian Pan United States
Young Mo Kang South Korea
Shuzhong Cui relative to Shuo Wang China Shuo Wang's profile →
Citations per field
00.5×1.5×1.8×
Shuo Wang · 1×
Citations per year

Countries citing papers authored by Shuzhong Cui

Since Specialization
Citations

This map shows the geographic impact of Shuzhong Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuzhong Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuzhong Cui more than expected).

Fields of papers citing papers by Shuzhong Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuzhong Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuzhong Cui. The network helps show where Shuzhong Cui may publish in the future.

Co-authorship network of co-authors of Shuzhong Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Shuzhong Cui. A scholar is included among the top collaborators of Shuzhong Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuzhong Cui. Shuzhong Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 1
5 1
6 2
7 1
8 2
9 4
10 5
11 5
12 13
13 127
14 59
15 49
16 20
17 4
18 65
19 96
20 45

About Shuzhong Cui

Shuzhong Cui is a scholar working on Cancer Research, Reproductive Medicine and Hepatology, having authored 91 papers that have together received 2.9k indexed citations. Recurring topics across this work include Intraperitoneal and Appendiceal Malignancies (17 papers), MicroRNA in disease regulation (13 papers) and Cancer-related molecular mechanisms research (11 papers). The work is most often cited by research in Cancer Research (884 citations), Oncology (668 citations) and Immunology (455 citations). Shuzhong Cui has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Hongsheng Tang, Lisi Zeng, Xiangliang Zhang, Jun Lin, Meifang Wang, Mengyu Chang, Zhiyao Hou, Binbin Ding, Man Wang and Mengmeng Shu. Their work appears in journals such as Advanced Materials, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026